🇺🇸 FDA
Patent

US 10314900

Lutzomyia longipalpis polypeptides and methods of use

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 10314900 (Lutzomyia longipalpis polypeptides and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K2039/575, A61K2039/58